Specifications
CLASS
Lateral-flow Immunoassays
COUNTRY OF ORIGIN
United States
PRECAUTIONARY STATEMENTS
Specimens may be infectious. Use universal precautions when performing this assay.
Use routine laboratory precautions. Avoid any contact between hands, eyes, or mouth
during sample collection and testing.
Use appropriate personal protective equipment (laboratory coat, gloves, and eye
protection) during patient sample handling. Wash hands thoroughly after handling
specimens.
All samples and materials used in this test procedure must be disposed in a biohazard
waste container. Proper handling and disposal methods should be established according
to local regulations. DO NOT USE the test if desiccant packet is missing. Discard test and use a new test.
DO NOT USE the test if the pouch was not sealed.
DO NOT USE the test beyond the expiration date stated on the pouch. Always check
expiration date prior to performing test.
DO NOT REUSE the test. Each test device is for single use only.
Ensure finger is completely dry before performing fingerstick.
*USAGE / SAFETY STATEMENT
The ADEXUSDx® COVID-19 Test is an in vitro lateral-flow immunoassay intended for qualitative detection of total antibodies to SARS-CoV-2 in human venous whole blood (dipotassium EDTA), plasma (dipotassium EDTA), serum, and fingerstick whole blood. The ADEXUSDx® COVID-19 Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARSCoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The ADEXUSDx® COVID-19 Test should not be used to diagnose or exclude acute SARS-CoV-2 infection.
REGULATORY NOTICE & RESTRICTIONS
For Emergency Use Authorization only. For prescription use only. For in vitro diagnostic use only. This product has not been FDA cleared or approved but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories. This product has been authorized only for detecting the presence of total antibodies to SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
QUALITY CERTIFICATION / COMPLIANCE
This product was manufactured in NOWDiagnostics, Inc. facilities based on a quality system compliant with GMP for Medical Devices and ISO 13485.
RESULT WINDOW
15-30 Minutes
SAMPLE TYPE
Human venous whole blood (dipotassium EDTA), plasma (dipotassium EDTA), serum, and fingerstick whole blood